Eris Lifesciences fundamental analysis
ERIS
1508.8
25.60 (-1.67%)Last updated on 9 Jan, 2026 | 15:56 IST
BUYSELL
The current prices are delayed, login to your account for live prices
Login Eris Lifesciences Fundamentals
P/E Ratio
50.27
P/B Ratio
6.76
Div. Yield
0.48
Sector P/E
71.12
Sector P/B
0.95
Sec. Div. Yield
0.56
Eris Lifesciences Fundamentals is currently trading with a P/E Ratio of 50.27, compared to the sector average of 71.12. Its P/B Ratio stands at 6.76, while the sector’s is 0.95. In terms of returns, the stock offers a Dividend Yield of 0.48%, which is than the sector’s 0.56%.
Eris Lifesciences Score Card
Price
Expensive
Growth
Poor
Quality
Good
Management
Good
On its scorecard, Eris Lifesciences reflects: Price – Expensive, Growth – Poor, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.
